Literature DB >> 20376092

Gastrointestinal bleeding: Endoscopic cyanoacrylate therapy for gastric variceal bleeding.

Norma C McAvoy1, Peter C Hayes.   

Abstract

Bleeding from gastric varices is relatively common and can be life threatening. The optimal treatment strategy for gastric variceal hemorrhage is controversial. Both interventional radiology and endoscopic therapies require a high level of clinical expertise. Which type of therapy is best? A recent study compared endoscopic cyanoacrylate glue injection with the insertion of a transjuglar intrahepatic portosystemic shunt.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20376092     DOI： 10.1038/nrgastro.2010.22

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  11 in total

1.  Risk factors for hemorrhage from gastric fundal varices.

Authors:  T Kim; H Shijo; H Kokawa; H Tokumitsu; K Kubara; K Ota; N Akiyoshi; T Iida; M Yokoyama; M Okumura
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

2.  A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices.

Authors:  G H Lo; K H Lai; J S Cheng; M H Chen; H T Chiang
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

3.  Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding.

Authors:  S Mahadeva; M C Bellamy; D Kessel; M H Davies; C E Millson
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

4.  Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.

Authors:  W Nolte; J Wiltfang; C Schindler; H Münke; K Unterberg; U Zumhasch; H R Figulla; G Werner; H Hartmann; G Ramadori
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

5.  Hepatic hemodynamic features in patients with esophageal or gastric varices.

Authors:  Y Chao; H C Lin; F Y Lee; S S Wang; Y T Tsai; H C Hsia; W J Lin; S D Lee; K J Lo
Journal:  J Hepatol       Date:  1993-08       Impact factor: 25.083

6.  Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.

Authors:  K A Somberg; J L Riegler; J M LaBerge; M M Doherty-Simor; P Bachetti; J P Roberts; J R Lake
Journal:  Am J Gastroenterol       Date:  1995-04       Impact factor: 10.864

7.  A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.

Authors:  G-H Lo; H-L Liang; W-C Chen; M-H Chen; K-H Lai; P-I Hsu; C-K Lin; H-H Chan; H-B Pan
Journal:  Endoscopy       Date:  2007-08       Impact factor: 10.093

8.  Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.

Authors:  S K Sarin; D Lahoti; S P Saxena; N S Murthy; U K Makwana
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

9.  Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis.

Authors:  Nicholas J Procaccini; Abdullah M S Al-Osaimi; Patrick Northup; Curtis Argo; Stephen H Caldwell
Journal:  Gastrointest Endosc       Date:  2009-06-25       Impact factor: 9.427

10.  Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.

Authors:  R Jalan; R A Elton; D N Redhead; N D Finlayson; P C Hayes
Journal:  J Hepatol       Date:  1995-08       Impact factor: 25.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.